Louis Stokes Cleveland Department of Veterans Affairs Medical Center
Cleveland, Ohio, 44118, United States
NCT Number: NCT01725659
PURPOSE. After stroke many patients are unable to engage in normal upper limb functional activities, which may restrict them from participation in meaningful life roles. For many, conventional rehabilitation does not restore upper limb function to a useful level. The purpose of this research is to investigate the benefits of three promising motor learning interventions: focused intensive, motor learning (FIML); 2) robotics and motor learning (ROB-ML); and 3) functional neuromuscular stimulation and motor learning (FNS-ML).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Cleveland, Ohio, 44118, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
training of the hemiplegic upper limb with motor learning
subjects perform training of hemiplegic arm using an upper extremity robot
subjects are provided with surface FES to the hemiplegic upper limb
Time frame: after 12 weeks of intervention
impairment measure of coordination of the upper limb
Malcom Randall VA Medical Center
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03453008
Brain Diseases, Cardiovascular Diseases
Toulouse, France
View Trial DetailsNCT06509542
Brain Diseases, Cardiovascular Diseases
Lamalou-les-Bains, France
View Trial DetailsNCT05241457
Brain Diseases, Cardiovascular Diseases
Schenectady, New York, United States
View Trial DetailsNCT04028999
Brain Diseases, Cardiovascular Diseases
Toulouse, France
View Trial Details